Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis

被引:123
作者
Wong, SY
Haack, H
Crowley, D
Barry, M
Bronson, RT
Hynes, RO
机构
[1] MIT, Howard Hughes Med Inst, Canc Res Ctr, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, Cambridge, MA 02139 USA
[3] Tufts Univ, Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA
关键词
D O I
10.1158/0008-5472.CAN-05-0901
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dissemination to draining lymph nodes is a frequent first step in prostate cancer metastasis. Although tumors metastasize to lymph nodes via the lymphatics, the importance of lymphangiogenesis in mediating the process remains controversial. Here, we inhibit intratumoral lymphangiogenesis in s.c. and surgical orthotopic implantation mouse models of human prostate cancer using several strategies. Stable expression of small interfering RNAs (siRNA) targeted against human vascular endothelial growth factor-C (VEGF-C) in PC-3 cells reduced intratumoral lymphatics by 99% in s.c. tumors, indicating that tumor-secreted VEGF-C is necessary for lymphangiogenesis. Expression of siRNAs against human VEGF-A somewhat reduced tumor lymphangiogenesis. Secretion of a soluble VEGF receptor-3/Flt4 fusion protein by PC-3 cells reduced intratumoral lymphatics by 100% in s.c. tumors. Combination of soluble Flt4 and VEGF-C siRNA yielded > 92% reduction of intratumoral lymphatics in orthotopic prostate tumors. However, metastasis to lymph nodes was not significantly affected regardless of intraturnoral lymphatic vessel density. The abundance of marginal lymphatics at the tumor-stromal interface was unchanged in orthotopic tumors whose intratumoral lymphatics were inhibited, suggesting that these marginal vessels could be sufficient for lymph node metastasis. Hematogenous metastasis (blood tumor burden, lung metastasis) correlated with degree of lymph node invasion. We also analyzed the lymphatics in spontaneous transgenic adenocarcinomas of the mouse prostate which metastasize to lymph nodes. Progression from well-differentiated prostate intraepithelial neoplasia to metastatic, undifferentiated adenocarcinoma was accompanied by loss of lymphatics. These results suggest that tumor-secreted VEGF-C and, to a lesser extent, VEGF-A, are important for inducing prostate cancer intratumoral lymphangiogenesis but are unnecessary for lymph node metastasis.
引用
收藏
页码:9789 / 9798
页数:10
相关论文
共 58 条
[1]   Focus on lymphangiogenesis in tumor metastasis [J].
Achen, MG ;
McColl, BK ;
Stacker, SA .
CANCER CELL, 2005, 7 (02) :121-127
[2]  
Alitalo Kari, 2004, Cancer Res, V64, P9225, DOI 10.1158/0008-5472.CAN-04-2475
[3]  
An ZL, 1998, PROSTATE, V34, P169
[4]  
[Anonymous], 2001, CURRENT PROTOCOLS IM
[5]   Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients [J].
Bubendorf, L ;
Schöpfer, A ;
Wagner, U ;
Sauter, G ;
Moch, H ;
Willi, N ;
Gasser, TC ;
Mihatsch, MJ .
HUMAN PATHOLOGY, 2000, 31 (05) :578-583
[6]   PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis [J].
Cao, RH ;
Björndahl, MA ;
Religa, P ;
Clasper, S ;
Garvin, S ;
Galter, D ;
Meister, B ;
Ikomi, F ;
Tritsaris, K ;
Dissing, S ;
Ohhashi, T ;
Jackson, DG ;
Cao, YH .
CANCER CELL, 2004, 6 (04) :333-345
[7]  
Chang XH, 1999, ANTICANCER RES, V19, P4199
[8]   Vascular endothelial growth factor and signaling in the prostate:: more than angiogenesis [J].
Chevalier, S ;
Defoy, I ;
Lacoste, J ;
Hamel, L ;
Guy, L ;
Bégin, LR ;
Aprikian, AG .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 189 (1-2) :169-179
[9]   Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis [J].
Crnic, I ;
Strittmatter, K ;
Cavallaro, U ;
Kopfstein, L ;
Jussila, L ;
Alitalo, K ;
Christofori, G .
CANCER RESEARCH, 2004, 64 (23) :8630-8638
[10]   Molecular pathway for cancer metastasis to bone [J].
De, S ;
Chen, JH ;
Narizhneva, NV ;
Heston, W ;
Brainard, J ;
Sage, EH ;
Byzova, TV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :39044-39050